Evidence map›Paper›PMID 24069360›Full record

ArticlePloS one2013

Virulence potential and genome-wide characterization of drug resistant Streptococcus pneumoniae clones selected in vivo by the 7-valent pneumococcal conjugate vaccine.

Nelson Frazão, N Luisa Hiller, Evan Powell, Josh Earl, Azad Ahmed, Raquel Sá-Leão, Hermínia de Lencastre, Garth D Ehrlich, Alexander Tomasz

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. IL-1 Signaling Prevents Alveolar Macrophage Depletion during Influenza andJournal of immunology (Baltimore, Md. : 1950) · 2018
    Article
  4. Puzzling Over the Pneumococcal Pangenome.Frontiers in microbiology · 2018
    Review
  5. Article
  6. Article
  7. Rise of multidrug-resistant non-vaccine serotype 15A Streptococcus pneumoniae in the United Kingdom, 2001 to 2014.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2016
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Nelson FrazãoLaboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, Portugal ; Laboratory of Microbiology, The Rockefeller University, New York, New York, United States of America.
N Luisa Hiller
Evan Powell
Josh Earl
Azad Ahmed
Raquel Sá-Leão
Hermínia de Lencastre
Garth D Ehrlich
Alexander Tomasz
Allegheny-Singer Research Institute · USRockefeller University · USAllegheny General Hospital · USUniversidade Nova de Lisboa · PT

Funding

MOLECULAR ANALYSIS OF PATHOGENS IN OTITIS MEDIA BY PCRR01DC002148 · NIDCD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI EHRLICH, GARTH D. · 1994 to 2017
$6.5M
Impact of Antibiotics and Vaccines on the in vivo Evolution of S. pneumoniaeR01AI080935 · NIAID · ALLEGHENY-SINGER RESEARCH INSTITUTE · PI EHRLICH, GARTH D. · 2009 to 2010
$1.3M
Insights from Comparative Genomics for the Treatment of Pneumococcal InfectionsR00DC011322 · NIDCD · CARNEGIE-MELLON UNIVERSITY · PI HILLER, NATALIA LUISA · 2012 to 2014
$718k
NIAID NIH HHS AI080935NIAID NIH HHS R01 AI080935NIDCD NIH HHS DC002148NIDCD NIH HHS DC02148 - 16S1NIDCD NIH HHS R00 DC011322NIDCD NIH HHS R00DC011322NIDCD NIH HHS R01 DC002148
6 · The paper itself

Abstract

We used mouse models of pneumococcal colonization and disease combined with full genome sequencing to characterize three major drug resistant clones of S. pneumoniae that were recovered from the nasopharynx of PCV7-immunized children in Portugal. The three clones--serotype 6A (ST2191), serotype 15A (ST63) and serotype 19A (ST276) carried some of the same drug resistance determinants already identified in nasopharyngeal isolates from the pre-PCV7 era. The three clones were able to colonize efficiently the mouse nasopharyngeal mucosa where populations of these pneumococci were retained for as long as 21 days. During this period, the three clones were able to asymptomatically invade the olfactory bulbs, brain, lungs and the middle ear mucosa and established populations in these tissues. The virulence potential of the three clones was poor even at high inoculum (10(5) CFU per mouse) concentrations in the mouse septicemia model and was undetectable in the pneumonia model. Capsular type 3 transformants of clones 6A and 19A prepared in the laboratory produced lethal infection at low cell concentration (10(3) CFU per mouse) but the same transformants became impaired in their potential to colonize, indicating the importance of the capsular polysaccharide in both disease and colonization. The three clones were compared to the genomes of 56 S. pneumoniae strains for which sequence information was available in the public databank. Clone 15A (ST63) only differed from the serotype 19F clone G54 in a very few genes including serotype so that this clone may be considered the product of a capsular switch. While no strain with comparable degree of similarity to clone 19A (ST276) was found among the sequenced isolates, by MLST this clone is a single locust variant (SLV) of Denmark14-ST230 international clone. Clone 6A (ST2191) was most similar to the penicillin resistant Hungarian serotype 19A clone.

Indexed as

AnimalsBacterial CapsulesDisease Models, AnimalDrug Resistance, BacterialFemaleGenome, BacterialGenome-Wide Association StudyMicePhylogenyPneumococcal InfectionsPneumococcal VaccinesPolymorphism, GeneticSequence Analysis, DNAStreptococcus pneumoniaeVaccines, ConjugateVirulencePneumococcal VaccinesVaccines, Conjugate

Identifiers

PMID24069360
PMCPMC3777985
OpenAlexW1971470136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.